Background: The dawn of the "omics" technologies has changed allergy research, increasing the knowledge and identification of new allergens. However, these studies have been almost restricted to Dermatophagoides spp. Although Blomia tropicalis has long been established as a clinically important source of allergens, a thorough proteomic characterization is still lacking for this dust mite.
Objective: To increase knowledge of B. tropicalis allergens through proteomic analysis.
Methods: Eleven in-bred lineages of B. tropicalis were obtained from 11 unique different pregnant females. Their somatic extracts were analyzed and compared with a commercially available extract by liquid chromatography tandem mass spectrometry (LC-MS/MS).
Results: Considerable differences in the protein expression profiles were found among the breeds, and most of them displayed higher expression levels of major allergens than the commercially available extract. Blo t 2 was the most prominent allergenic protein in the analyzed extracts. Six identified allergens and 14 isoforms have not yet been recognized by IUIS. Conversely, 3 previously recognized B. tropicalis allergens were not found.
Conclusions: The clear impact of inbreeding on allergen content shown by our study leads us to conclude that the quantification and/or identification of allergens from in-bred lines should be routinely considered for mite cultivation in order to select breeds with higher amounts of major allergens. In this sense, LC-MS/MS may be a useful method to achieve this quality control for research and commercial purposes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000501964 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Trial With a Depigmented, Polymerized Mite Mixture Extract at Maximum Concentrations.
Immun Inflamm Dis
December 2024
Medical Affairs and Clinical Department, LETI Pharma S.L.U., Madrid, Spain.
Background: Efficacy of allergen immunotherapy is dose-dependent; however, high doses of allergen may imply a greater risk of adverse reactions.
Objective: To assess the safety and tolerability of subcutaneous immunotherapy (SCIT) with mixtures of mite allergen extracts, Dermatophagoides pteronyssinus/Blomia tropicalis (Dpt/Bt) and Dermatophagoides pteronyssinus/Lepidoglyphus destructor (Dpt/Ld) at maximum concentrations, in adult patients with allergic rhinitis or rhinoconjunctivitis, and controlled allergic asthma due to a clinically relevant sensitisation to these mites.
Methods: An open-label, noncontrolled, nonrandomised, phase IIb clinical trial was carried out in three hospitals in Spain between September 2014 and May 2018.
Blomia tropicalis: A 50-Year History.
J Allergy Clin Immunol Pract
November 2024
Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, Fla.
Article Synopsis
- * The discovery of 26 B. tropicalis allergens, some cross-reactive with other mite species, complicates diagnosis and treatment options for allergies, though advancements in component-resolved diagnostics aid in this process.
- * Immunotherapy using B. tropicalis extracts is effectively implemented in various countries, but there is a challenge with the limited availability of standardized extracts, despite significant research contributions over the past five decades on allergen characterization and potential impacts of climate change.
Nasal allergen challenge with Blomia tropicalis in children and adolescents.
Allergol Immunopathol (Madr)
November 2024
Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.
Background: Local allergic rhinitis (LAR) is a well-defined phenotype in adults, but still there is little data available on children. This scarcity of data can be partly attributed to the lack of standardized protocols for Nasal Allergen Challenges (NAC) in this demographic.
Methods: 20 controls (control group) and 24 patients (rhinitis group) with allergic rhinitis diagnosis sensitized to Blomia tropicalis (Bt) underwent the NAC with Bt.
Agreement of Peru-Based Allergy Tests for Respiratory Allergens in Allergic Rhinitis Patients.
J Immunol Res
November 2024
SANNA el Golf Clinic, Lima, Peru.
Article Synopsis
- The study evaluated the agreement between three allergy testing methods—Peruvian Immunoblot, SPT (skin prick tests), and ALEX-2—in patients with allergic rhinitis in Arequipa, Peru.
- 35 patients participated, with findings indicating varying sensitization rates for allergens not covered by the Immunoblot panel.
- The results revealed stronger concordance between ALEX-2 and SPT compared to the agreement between Immunoblot and SPT.
NMR residual dipolar couplings investigation in the topology of house dust mite Group V allergens.
J Struct Biol
December 2024
Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. Electronic address:
Blo t 5 is an important major allergen protein from Blomia tropicalis mites, which are prevalent in tropical and subtropical regions, including Taiwan. It is a coiled-coil triple helical bundle, but there currently is ambiguity around its structural fold and packing of the three helices. We have relied on NMR residual dipolar coupling data collected from four different alignment media to confirm that Blo t 5 has left-handed helical topology and further used that data to refine its solution structure.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!